compounded glp 1 ending GLP-1 - Semaglutide & Tirzepatide Patients struggle as compounded GLP-1

A phase 3b, randomized, multicenter, controlled study of mirikizumab and placebo or mirikizumab concomitantly administered with tirzepatide in adult participants with moderately to severely active ulcerative colitis and obesity or overweight

Funding The authors received no financial support for this study

Works in harmony with probiotics from Green Supremefood to support gut balance

The mean time to restarting was 177 days longer in obesity than in T2DM

Important Information: If you are already taking vitamin D supplements, you will need to stop taking the supplement for 4 weeks before receiving a vitamin D injection